Welcome to the REACH Awards

The Research and Advancement in Cardiorenal Health (REACH) Awards
is brought to you as a joint effort by Bayer and the American Academy of
Family Physicians (AAFP). The REACH Awards aim to support investigator
research in the areas of

.
All healthcare professionals (HCPs), fellows, clinical researchers, scientists, and
epidemiologists currently working within the field of CKM diseases in the United States may apply.
 

Program objectives

To support needed clinical or population research in innovative and understudied 
areas within the CKM health space, including but not limited to:
⦁    Identification, diagnosis, and monitoring of patients with CKM syndrome
⦁    The prevalence of CKM syndrome and CKM-related outcomes in key populations
⦁    The role of primary care in CKM health
⦁    The benefits of pharmacotherapies for treating CKM syndrome       
⦁    The implementation of guideline-directed medical therapies for treating CKM disease
 

About the REACH Awards

Nine awards are available for the 2026/2027 cycle, each worth up to
US $20,000 per recipient to support one year of research. 

Applicants must submit Letter of Intent (LOI) proposals by

, to be eligible for the REACH Awards 2026/2027 cycle. 

Apply for the REACH Awards 

Gather the required information and submit your LOI proposal by

, by emailing the document to
REACHAwards@porterhousemedical.com.